Quaternary prevention and off label medication in the covid pandemic

Article Sidebar

Revista INFAD. Número 1, volumen 1 de 2021
PDF (Português (Portugal))
Published: Aug 3, 2021
DOI: https://doi.org/10.17060/ijodaep.2021.n1.v1.2074

Main Article Content

Júlia Maria Guilherme Ribeiro Antunes
Médica e Médica Dentista Instituto Universitário Egas Moniz (IUEM) Prof. Auxiliar

Abstract

The lack of effective therapy for covid-19 infection, paved the way for an exacerbated trial / error empiricism to find treatment solutions at any price, to stop this disease that was and continues to be deadly, practically all over the Planet. The proposal to apply the principle of beneficence as a basis for the use of off-label medicines, in the treatment of COVID-19, part of the need to offer the physician the theoretical parameters capable of supporting an ethically acceptable decision, on the other hand, the indiscriminate use of medicines off label offers huge individual risks and dreams of big profits, with little investments, for Big Pharma, configuring these current practices, the need for intervention of quaternary prevention, since the medicalization of society continues to be part of the current sanitary imperialism, allowing the absence of care with iatrogenesis, as well as, with overdiagnosis, overmedicalization, overtreatment, overscreenings, overinformation, present in the medical praxis where watchful waiting and the delay allowed, are new ways of attending and caring for individuals and their families.

Downloads

Download data is not yet available.

Article Details

How to Cite
Ribeiro Antunes, J. M. G. (2021). Quaternary prevention and off label medication in the covid pandemic. International Journal of Developmental and Educational Psychology. Revista INFAD De Psicología., 1(1), 357–362. https://doi.org/10.17060/ijodaep.2021.n1.v1.2074
Issue
Vol. 1 No. 1 (2021): POSITIVE OVERCOMING AND LEARNING: THE RESPONSE TO COVID-19
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:
 
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to copy and redistribute the material in any medium or format under the following terms:

 

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

NonCommercial — You may not use the material for commercial purposes.

NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.

 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
 
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
 
The authors are responsible to obtain the appropriate permissions to reproduce material (text, images or graphics) from other publications and to quote their origin correctly.
 

References

AGUIAR, M., & da SILVA, C. M. A. (2020). O PRINCÍPIO DA BENEFICÊNCIA COMO FUNDAMENTO À PRESCRIÇÃO DE MEDICAMENTOS OFF LABEL NO TRATAMENTO DA COVID-19. Revista Juridica, 5(62), 76-95.

Antunes, J. M. G. R. (2018). Novas lógicas, racionalidaes e contextos na prevençao quaternária. Revista INFAD de Psicología. International Journal of Developmental and Educational Psychology., 4(1), 99-106.

Antunes, J. M. G. R. (2019). A prevenção quaternária e o iceberg das pseudo–doenças, incidentalomas e afins!. International Journal of Developmental and Educational Psychology. Revista INFAD de Psicología., 5(1), 411-416.

Radley, D. C., Finkelstein, S. N., & Stafford, R. S. (2006). Off-label prescribing among office-based physicians. Archives of internal medicine, 166(9), 1021-1026.

Cras, A., Conscience, M. A., Rajzbaum, G., Lillo-Le Louët, A., Lopez, N., Tersen, I., & Bezie, Y. (2007). Off-label prescribing in a French hospital. Pharmacy world & science, 29(2), 97-100.

Childress, J. F. (1998). A principle-based approach.

Beauchamp, T. L., & Childress, J. F. (2002). Princípios de ética biomédica. Edições Loyola.

Garcia, L. P., & Duarte, E. (2020). Intervenções não farmacológicas para o enfrentamento à epidemia da COVID-19 no Brasil.

Paumgartten, F. J. R., & Oliveira, A. C. A. X. D. (2020). Uso off label, compassivo e irracional de medicamentos na pandemia de Covid-19, consequências para a saúde e questões éticas. Ciência & Saúde Coletiva, 25(9),3413-3419.

Souza Filho, B. A. B. D., & Tritany, É. F. (2020). COVID-19: importância das novas tecnologias para a prática de atividades físicas como estratégia de saúde pública. Cadernos de Saúde Pública, 36, e00054420.

World Health Organization. (2002). Promoting rational use of medicines: core components (No. WHO/EDM/2002.3). World Health Organization.

Tritany, R. F., & Tritany, É. F. (2020). Uso Racional de Medicamentos para COVID-19 na Atenção Primária à Saúde. Saúde em Redes, 6(2 Suplem).

Martins, C., Godycki-Cwirko, M., Heleno, B., & Brodersen, J. (2018). Quaternary prevention: reviewing the concept: Quaternary prevention aims to protect patients from medical harm. European Journal of General Practice, 24(1), 106-111.